Canada markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
21.13-0.73 (-3.34%)
At close: 4:00PM EDT
21.13 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
Total Revenue
862
0
0
Operating Expenses
Research Development
8,481
3,041
2,999
Selling General and Administrative
3,828
1,802
772
Total Operating Expenses
12,309
4,843
3,771
Operating Income or Loss
-11,447
-4,843
-3,771
Interest Expense
0
206
233
Total Other Income/Expenses Net
-
-1,735
-
Income Before Tax
-11,401
-6,784
-4,004
Income from Continuing Operations
-11,401
-6,784
-4,004
Net Income
-11,401
-6,784
-4,004
Net Income available to common shareholders
-11,401
-6,784
-4,004
Basic EPS
-
-1.06
-0.62
Diluted EPS
-
-1.06
-0.62
Basic Average Shares
-
6,415
6,415
Diluted Average Shares
-
6,415
6,415
EBITDA
-
-6,565
-3,765